Improved outcome in childhood acute myeloid leukemia in Singapore with the MRC AML 10 protocol

Pediatric Blood and Cancer

Volumn 48, Issue 3, 2007, Pages 262-267

  Tan, Ronald M ^a   Thuan, Chong Quah ^a   Aung, LeLe ^b   Liang, Shen ^c   Kirk, Richard C ^d   Yeoh, Allen E J ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

^c Johns Hopkins Singapore   (Singapore)

^d FREEMAN HOSPITAL   (United Kingdom)

Author keywords

AML; MRC AML 10; Survival; Toxicity

Indexed keywords

AMSACRINE; ANTHRACYCLINE; AZACITIDINE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; PREDNISONE; TIOGUANINE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER CHEMOTHERAPY; CARDIOTOXICITY; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; COMBINATION CHEMOTHERAPY; DISEASE FREE SURVIVAL; DRUG MEGADOSE; FEBRILE NEUTROPENIA; FEMALE; GASTROINTESTINAL SYMPTOM; HEPATITIS; HUMAN; INFECTION; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MALE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NEPHROTOXICITY; NEUTROPENIA; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGAPORE; THROMBOCYTOPENIA; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

6-MERCAPTOPURINE; ACUTE DISEASE; AMSACRINE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AZACITIDINE; CHILD; CHILD, PRESCHOOL; CYTARABINE; DAUNORUBICIN; DEVELOPING COUNTRIES; DISEASE-FREE SURVIVAL; DRUG EVALUATION; ETOPOSIDE; FEMALE; GASTROINTESTINAL DISEASES; HEART DISEASES; HEMATOLOGIC DISEASES; HEPATITIS, TOXIC; HUMANS; INFANT; INFECTION; KAPLAN-MEIERS ESTIMATE; LEUKEMIA, MYELOID; MALE; METHOTREXATE; MITOXANTRONE; PREDNISONE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SINGAPORE; SURVIVAL ANALYSIS; THIOGUANINE; TREATMENT OUTCOME; VINCRISTINE;

EID: 33846898258     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20834     Document Type: Article

References (26)

1. Arceci RJ. Progress and controversies in the treatment of pediatric acute myelogenous leukemia. Curr Opin Hematol 2002;9:353-360.
2. Loeb DM, Arceci RJ. Treatment of childhood acute myeloid leukemia. In: Pui CH, editor. Treatment of acute leukemias: New directions for clinical research. New Jersey: Humana Press, 2003. pp 255-265.
3. Creutzig U. Treatment of acute myeloid leukemia in children. In: Pui CH, editor. Treatment of acute leukemias: New directions for clinical research. New Jersey: Humana Press, 2003. pp 237-254.
4. Langmuir PB, Aplenc R, Lange BJ. Acute myeloid leukaemia in children. Best Pract Res Clin Haematol 2001;14:77-93.
5. Chessells J. Acute myeloid leukaemia. In: Pinkerton R, Philip T, Fervers B, editors. Evidence-based paediatric oncology. London: BMJ Books, 2002. pp 251-287.
6. Pui CH. Childhood leukemias. N Engl J Med 1995;332:1618-1627.
7. Creutzig U, Zimmerman M, Reinhardt D, et al. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: Analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. J Clin Oncol 2004;22:4384-4393.
8. Hann I, Webb DKW, Gibson BES, et al. MRC trials in childhood acute myeloid leukaemia. Ann Hematol 2004;83:108-112.
9. Woods WG. Curing childhood acute myeloid leukemia (AML) at the half-way point: Promises to keep and miles to go before we sleep. Pediatr Blood Cancer 2005;46:565-569.
10. Quah TC, Sun L, Chew FT, et al. Survival of childhood leukemia in Singapore. Med Pediatr Oncol 1996;26:318-324.
11. th AML trial. Br J Haematol 1998;101:130-140.
12. Ravindranath Y, Steuber CP, Krischer J, et al. High-dose cytarabine for intensification of early therapy of childhood acute myeloid leukemia: A Pediatric Oncology Group study. J Clin Oncol 1991;9:572-580.
13. Woods WG, Kobrinsky N, Buckley JD, et al. Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: A report from the Children's Cancer Group. Blood 1996;87:4979-4989.
14. Ravindranath Y, Yeager AM, Chang MN, et al. Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. N Engl J Med 1996;334:1428-1434.
15. Creutzig U, Harbott J, Sperling C. Does cranial irradiation reduce the risk for bone marrow relapse in acute myelogenous leukemia? Unexpected results of the Childhood Acute Myelogenous Leukemia Study BFM-87. J Clin Oncol 1993;11:279-286.
16. Creutzig U, Ritter J, Schellong G, et al. Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78. Blood 1990;75:1932-1940.
17. Steuber CP, Civin C, Krischer J, et al. A comparison of induction and maintenance therapy for acute non-lymphoblastic leukemia in childhood: Results of a POG study. J Clin Oncol 1991;9:247-258.
18. Loeb DM, Bowers DC, Civin CI, et al. Intensive timed sequential remission induction chemotherapy with high-dose cytarabine for childhood acute myeloid leukemia. Med Pediatr Oncol 2001;37:365-371.
19. Webb DKH, Harrison G, Stevens RF, et al. Relationships between age at diagnosis, clinical features, and outcome of therapy in children treated in the Medical Research Council AML 10 and 12 trials for acute myeloid leukemia. Blood 2001;98:1714-1720.
20. Lowenberg B. Prognostic factors in acute myeloid leukaemia. Best Pract Res Clin Haematol 2001;14:65-75.
21. Ravindranath Y, Chang M, Steuber CP, et al. Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): A review of four consecutive childhood AML trials conducted between 1981 and 2000. Leukemia 2005;19:2101-2116.
22. Chan LL, Abdel-Latif ME, Ariffin WA, et al. Treating childhood acute myeloid leukaemia with the AML-BFM-83 protocol: Experience in a developing country. Br J Haematol 2004;126:799-805.
23. Quah TC, Wong HB, Yip WCL, et al. Treatment and follow-up of acute leukaemia in children between 1973 and 1982. J Singapore Pediatr Soc 1983;25:63-69.
24. Krischer JP, Epstein S, Cuthbertson DD, et al. Clinical cardiotoxicity following anthracycline treatment for childhood cancer: The Pediatric Oncology Group experience. J Clin Oncol 1997;15:1544-1552.
25. Lipschultz SE, Lipsitz SR, Sallan SE, et al. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol 2005;23:2629-2636.
26. Leung W, Hudson MM, Strickland DK, et al. Late effects of treatment in survivors of childhood acute myeloid leukemia. J Clin Oncol 2000;18:3273-3279.